ABSTRACT
Introduction Sarcopenia is characterized by the progressive weakening of muscle function that occurs with age. This condition frequently leads to frailty, disability, and even death. Research on sarcopenia prevention is growing. Tele-exercise intervention is increasingly gaining attention in this field, with the rapid advancement of the Internet and the influence of the COVID-19. However, there is a lack of empirical support for its effectiveness. Our study aims to assess the effect of tele-exercise on sarcopenia in older persons, specifically focusing on its ability to improve muscle strength, muscle mass and physical performance.
Methods and analysis Searching will be performed in the following eleven databases (Medline, Embase, Cochrane Central Register of Controlled Trials, CINAHL, PsycINFO, WOS, Scopus, CBM, CNKI, WANFANG, VIP) for published trials and two trial registries (Clinicaltrials.gov and the WHO International Clinical Trials Registry Platform) for unpublished trials. Google Scholar will be utilized to find grey literatures. The criterion of inclusion will be clinical trials involving tele-exercise interventions in older adults (≥ 60y) diagnosed with sarcopenia (possible, confirmed, or severe sarcopenia). For data synthesis, we will utilize a summary table to show the major characteristics of selected trials and a summary graph to demonstrate the risk of bias using RoB 2 in each trial, which will be further discussed in a narrative synthesis. The possibility of meta-analysis for quantitative data will be assessed according to the homogeneity analysis of the trials, using the methods of fixed or random effects model. If meta-analysis is possible, subgroup analysis and sensitivity analysis will be performed as well. Publication bias will be assessed through the use of the funnel plot and Egger’s linear regression test when an adequate number of trials are available. Finally, the GRADE approach will be used to classify the certainty of evidence body into four categories (high, moderate, low, and very low).
Ethics and dissemination The findings of the systematic review will be shared through publishing in a peer-reviewed journal and presentation at appropriate conferences. Since we will not be utilizing specific patient data, ethical approval is unnecessary.
PROSPERO registration number CRD42024516930
Strengths and limitations of this study
- This will be the first systematic review on tele-exercise for sarcopenia prevention in older adults.
- This review will seek to determine the duration, frequency, intensity and type of tele-exercise that is most appropriate for preventing and treating sarcopenia.
- The results may fill the gap pertaining to accurate tele-exercise prescription in older adults with sarcopenia.
- This review will adhere to the PRISMA standards for conducting and reporting systematic reviews and meta-analyses in order to reduce bias.
- High heterogeneity may exist due to the different diagnostic criteria and thresholds for sarcopenia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
YS is funded by the University of Manchester - China Scholarship Council Joint Scholarship (202108320049), and CT is funded by the National Institute for Health and Care Research Senior Investigator Award (NIHR200299). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Email adress Ya Shi: ya.shi{at}postgrad.manchester.ac.uk, Emma Stanmore: emma.stanmore{at}manchester.ac.uk, Lisa Mcgarrigle: lisa.mcgarrigle{at}manchester.ac.uk, Chris Todd: chris.todd{at}manchester.ac.uk
Twitter Emma Stanmore @emmastanmore, Lisa McGarrigle @mcgarrigle_lisa, Chris Todd @Prof_Chris_Todd
Funding YS is funded by the University of Manchester - China Scholarship Council Joint Scholarship (202108320049), and CT is funded by the National Institute for Health and Care Research Senior Investigator Award (NIHR200299). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests None declared.
Patient and public involvement No patients involved.
Patient consent for publication Not required.
Consent for publication All authors approved the submission.
Ethics approval Not applicable.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data sharing not applicable as no data sets generated and/or analysed for this study.
Data Availability
Data sharing not applicable as no data sets generated and/or analysed for this study.
